May 2 - 3, 2013    Boston MA , USA

Bispecific and multiclonal antibodies are one of the most promising and exciting areas of protein engineering. The range of therapeutic uses for bispecific antibodies is expanding beyond oncology to target diseases of the immune system, heart and CNS. This meeting will discover the remaining challenges and creative problem solving that have been used to make successful bispecific formats. The latest solutions for improving efficacy and minimizing toxicity will be explored.

Venue

Location: Seaport World Trade Center Boston
The Boston World Trade Center is a part of a non-profit organization which promotes the growth of World Trade Centers by developing international business relationships through a cooperative exchange..
Contact 200 Seaport Boulevard , MA 02210 Boston , USA
617.385.4212